SCHEMBL9918117

SCHEMBL9918117

O[Si](c1ccccc1)(c1ccccc1)c1cccc(N(c2ccccc2)c2ccccc2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
TDP1 Q9NUW8 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
KDM4E B2RXH2 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CRHBP P24387 1/20 0.33
ATM Q13315 1/20 0.33
CRHR2 Q13324 1/20 0.33
TLR9 Q9NR96 1/20 0.33
NPSR1 Q6W5P4 1/20 0.31
GLA P06280 1/20 0.31
TSHR P16473 1/20 0.31
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9918118 0.81 NR1H2 (0.42) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL8514131 0.79 ALDH1A1 (0.35) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL25672890 0.79 ALDH1A1 (0.41) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL9918116 0.77 ALDH1A1 (0.33) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL25673074 0.76 ALDH1A1 (0.43) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL9918119 0.76 SLC6A2 (0.36) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL9918120 0.75 ALDH1A1 (0.36) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL12936130 0.75 ALDH1A1 (0.55) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL5858491 0.75 ALDH1A1 (0.55) ALDH1A1TDP1L3MBTL1KDM4ECYP1A2
SCHEMBL49883 0.75 ESR1 (0.42) ALDH1A1TDP1L3MBTL1KDM4ECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575384-B2 Silanol-containing triarylamine derivatives SHIN-ETSU CHEMICAL CO., LTD. (JP) 2013-11-05 US disclosed
US-20120149913-A1 SILANOL-CONTAINING TRIARYLAMINE DERIVATIVES SHIN-ETSU CHEMICAL CO., LTD. (JP) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149913-A1 SILANOL-CONTAINING TRIARYLAMINE DERIVATIVES SIK2, AS3MT, ILK ALDH1A1 1233/4885TDP1 2831/4885L3MBTL1 2370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.